New preclinical data offers proof-of-principle for a combination immunotherapy that suppresses tumor growth in the liver. Current therapies for liver cancer are largely ineffective, resulting in poor outcomes.
from Top Health News -- ScienceDaily https://ift.tt/2T3MjPW
No comments:
Post a Comment